Patton, John
Brewer, Carmen
Chien, Wade
Johnston, Jennifer J
Griffith, Andrew J
Biesecker, Leslie G
Article History
Received: 23 December 2015
Revised: 4 September 2016
Accepted: 13 September 2016
First Online: 19 October 2016
Competing interests
: LGB receives royalties from Genentech and honoraria from Wiley-Blackwell and is an uncompensated advisor to the Illumina Corp. AJG holds U.S. patents: 7 166 433 (Transductin-2 and Applications to Hereditary Deafness), 7 192 705 (Transductin-1 and Applications to Hereditary Deafness), and 7 659 115 (Nucleic Acid Encoding Human Transductin-1 Polypeptide) and has a pending licensing agreement with EMD/Millipore for anti-TMC antibodies.